Abstract
Macular edema is a swelling of the macula that can result in decreased visual acuity. Because the macula is extensively surrounded by blood vessels, any resulting leakage can lead to macular edema and subsequent visual loss. Such leakage can be secondary to retinitis pigmentosa, and other retinal diseases including diabetic retinopathy, retinal vein occlusion, inflammatory processes such as uveitis, or can be a result of ocular surgery, referred to as Irvine-Gass Syndrome.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Antcliff, R.J., Spalton, D.J., Stanford, M.R., Graham, E.M., Ffytche, T.J. & Marshall, J. (2001). Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology, 108:765–72.
Beer, P.M., Bakri, S.J., Singh, R.J., Liu, W., Peters, G.B., 3rd & Miller, M. (2003). Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology, 110:681–6.
Bresnick, G.H. (1983). Diabetic maculopathy. A critical review highlighting diffuse macular edema. Ophthalmology, 90:1301–17.
Bresnick, G.H. (1986). Diabetic macular edema. A review. Ophthalmology, 93:989–97.
Brooks, H.L., Jr., Caballero, S., Jr., Newell, C.K., Steinmetz, R.L., Watson, D., Segal, M.S., Harrison, J.K., Scott, E.W. & Grant, M.B. (2004). Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone. Arch Ophthalmol, 122:1801–7.
Funatsu, H., Yamashita, H., Ikeda, T., Mimura, T., Eguchi, S. & Hori, S. (2003). Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema. Ophthalmology, 110:1690–6.
Heckenlively, J.R., Jordan, B.L. & Aptsiauri, N. (1999). Association of antiretinal antibodies and cystoid macular edema in patients with retinitis pigmentosa. Am J Ophthalmol, 127:565–73.
Hockley, D.J., Tripathi, R.C. & Ashton, N. (1979). Experimental retinal branch vein occlusion in rhesus monkeys. III. Histopathological and electron microscopical studies. Br J Ophthalmol, 63:393–411.
Ip, M.S., Gottlieb, J.L., Kahana, A., Scott, I.U., Altaweel, M.M., Blodi, B.A., Gangnon, R.E. & Puliafito, C.A. (2004). Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion. Arch Ophthalmol, 122:1131–6.
Jonas, J.B., Degenring, R.F., Kamppeter, B.A., Kreissig, I. & Akkoyun, I. (2004). Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema. Am J Ophthalmol, 138:158–60.
Jonas, J.B., Kreissig, I., Sofker, A. & Degenring, R.F. (2003). Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol, 121:57–61.
Klein, R., Klein, B.E., Moss, S.E., Davis, M.D. & DeMets, D.L. (1984). The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology, 91:1464–74.
Martidis, A., Duker, J.S., Greenberg, P.B., Rogers, A.H., Puliafito, C.A., Reichel, E. & Baumal, C. (2002). Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology, 109:920–7.
Massin, P., Audren, F., Haouchine, B., Erginay, A., Bergmann, J.F., Benosman, R., Caulin, C. & Gaudric, A. (2004). Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial. Ophthalmology, 111:218–24; discussion 224-5.
Sallum, J.M., Farah, M.E. & Saraiva, V.S. (2003). Treatment of cystoid macular edema related to retinitis pigmentosa with intravitreal triamcinolone acetonide: case report. Adv Exp Med Biol, 533:79–81.
Saraiva, V.S., Sallum, J.M. & Farah, M.E. (2003). Treatment of cystoid macular edema related to retinitis pigmentosa with intravitreal triamcinolone acetonide. Ophthalmic Surg Lasers Imaging, 34:398–400.
Yoshikawa, K., Kotake, S., Ichiishi, A., Sasamoto, Y., Kosaka, S. & Matsuda, H. (1995). Posterior sub-Tenon injections of repository corticosteroids in uveitis patients with cystoid macular edema. Jpn J Ophthalmol, 39:71–6.
Zamir, E., Read, R.W., Smith, R.E., Wang, R.C. & Rao, N.A. (2002). A prospective evaluation of subconjunctival injection of triamcinolone acetonide for resistant anterior scleritis. Ophthalmology, 109:798–805; discussion 805-7.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Science+Business Media, Inc.
About this paper
Cite this paper
Wang, C. et al. (2006). Intravitreal Injection of Triamcinolone Acetonide for Macular Edema Due to Retinitis Pigmentosa and Other Retinal Diseases. In: Hollyfield, J.G., Anderson, R.E., LaVail, M.M. (eds) Retinal Degenerative Diseases. Advances in Experimental Medicine and Biology, vol 572. Springer, Boston, MA. https://doi.org/10.1007/0-387-32442-9_43
Download citation
DOI: https://doi.org/10.1007/0-387-32442-9_43
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-28464-4
Online ISBN: 978-0-387-32442-5
eBook Packages: MedicineMedicine (R0)